Searched for
TRADE MARGIN CAPS
Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...- Largecaps over SMIDs: Ambit’s Nitin Bhasin and Bharat Arora share their Samvat 2083 strategyAs we step into the new Samvat, investors are advised to take a more cautious stance with their portfolios. The focus should be on large-ca...
- Diwali sweet nothings: Like soan papdi, the annual festival stock tip is admired, passed along, and almost never 'eaten'Diwali gifting traditions influence stock market trading strategies and recommendations across various brokerages during the festive season...
- Smallcap SIP returns turn negative over 3 years despite high valuations. Should investors worry?Smallcap SIP returns have slowed sharply, falling from nearly 40% in 2024 to mid-single digits in 2026 and approaching negative territory, ...
- Explained: 5 reasons why Trump’s midterm election setback matters for Indian markets and economyDonald Trump’s midterm election setback has triggered a global market rally, with Indian equities gaining sharply. Lower crude oil prices, ...
- Strong balance sheet, domestic focus, and a moat matter more: 5 large-cap stocks with upside potential of up to 24%The big event the market was waiting for has come and gone. So, is there greater clarity about where the crisis in the Gulf is headed? Not ...
- BSE Q2 Results: Net profit surges 45% YoY to Rs 809 crore; revenue jumps 34%BSE on Wednesday reported a 44.9% year-on-year rise in consolidated net profit to Rs 809.15 crore for the second quarter of FY27 (Q2FY27), ...
- Diwali 2026: Will Sensex, Nifty reclaim their peaks or scale new highs? Analysts map the road aheadMarket analysts are tentatively optimistic about Indian equity markets seeing a resurgence in the next financial year. Expectations suggest...
- For investors with a 3- to 5-year horizon: 5 mid-cap stocks from different sectors with upside potential of more than 19%A development worth noting is that there was net FII buying in five of the last six trading sessions. But it is still tentative, and cannot...
- Why did market rally today? Sensex jumps 1,225 pts, Nifty closes above 23,800. 6 key factors behind today's surgeThe Indian stock market witnessed a notable uptick on Tuesday, with Sensex and Nifty showing substantial growth. This surge was primarily d...
- Cancer drug prices fell in 2019 too, but mark-ups of up to 700% are backThe government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicine...
- Beyond tech: Kotak MF’s Shibani Kurian on India’s next innovation-led winnersInnovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...
- FPIs pull out Rs 34,843 cr from equities in Oct; turn net buyers last weekAmidst rising economic fears, foreign portfolio investors withdrew Rs 34,843 crore from Indian equities in October. Although they had made ...
- Varun Beverages shares fall over 4% as Q3 margin pressure weighs despite a 33% YoY revenue growthVarun Beverages reported strong Q3 CY2026 revenue, profit and volume growth, but its shares fell as higher packaging costs weighed on margi...
- NPPA list brings little relief: No price cut for 25% cancer drugsNearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...
- Advance-decline ratio hits 7-month low as market breadth weakensThe advance-to-decline ratio in the stock market indicates underlying weakness, despite some index gains. The BSE MidCap 150 and BSE SmallC...
- India’s drug pricing policy must balance affordability, medicine availability and pharma industry growthThe Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussi...
- Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrowIndia should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a...
- Cancer care can be cheaper: 6 steps to cut drug costsIndia has capped trade margins at 30% on 137 non-scheduled anti-cancer drugs to reduce treatment costs. Experts call for standardised care,...
- DRL says cap on trade margins a positive, posts 36% dip in Q2 PATIn the second quarter of FY2027, Dr. Reddy's Labs experienced a downturn in both revenue and profit. However, the company supports new trad...
Load More
